Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News

June 2010

Dental News Roundup June 2010 BY LAUREN UZDIENSKI, JUNE 30, 2010

Biomet reports F4Q:10 earnings . . . Discus Dental acquires Zap Lasers . . . Euroteknika launches Universal + implant system in the U.K. . . . 20% of Britons are missing five teeth or more . . . 3M closing an Oklahoma plant used by its Espe dental products unit . . . Fibrocell Science appoints three new clinical advisors more

FDA to Release 510(k) Report BY LAUREN UZDIENSKI, JUNE 29, 2010

MassDevice reports that the results of the FDA's internal study of the 510(k) process may be available in the next few weeks. While CDRH director Jeff Shuren has kept quiet on any potential changes that may be implemented (the center had previously targeted September for certain revisions to the 510(k) process), he did confirm that "we're not recommending to get rid of the 510(k) program." more

FDA Sets Panel Date for Amplify, Medtronic's Other BMP-2 BY LAUREN UZDIENSKI, JUNE 28, 2010

The FDA announced that on July 27, a CDRH panel will convene to discuss the PMA for Medtronic's Amplify, a BMP-2 matrix designed for single-level posterolateral lumbar fusions. The material has a different formulation and carrier than InFuse and is indicated as a treatment for degenerative disc disease. more

Musculoskeletal News Roundup 24-Jun-10 BY LAUREN UZDIENSKI, JUNE 24, 2010

Baxano closes $30M series C . . . SpineForm, Lanx, OrthoHelix receive $1M Ohio Third Frontier Commission awards . . . Aesculap launches S4 MIS Cannulated Pedicle Screw Spine Fusion System . . . Medtronic launches KYPHON ActivOs 10 Bone Cement with Hydroxyapatite . . . SNN granted injunction against Arthrex . . . Senate passes Medicare pay patch . . . Kensey Nash, Arthrex sign agreement over KNSY's ECM . . . Therapure, ProChon Biotech ink manufacturing deal . . . NuVasive leases NJ office space . . . BioTime creates new stem cell subsidiary more

BioHorizons, Inc. Files Registration Statement for Initial Public Offering of Common Stock BY EDITOR, JUNE 24, 2010

BioHorizons, Inc. today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock. more

Even in a Downturn, Devices are a "Strong and Vibrant" Sector of Economy BY LAUREN UZDIENSKI, JUNE 23, 2010

Touting the industry as a "critical" component of the U.S. economy, AdvaMed released a report on the health of the medical technology sector - demonstrating that even amid an economic slowdown, devices added jobs, grew worker pay and contributed $136... more

Chinese Device maker Trauson to IPO BY JAKE NORD, JUNE 21, 2010

Chinese orthopedic device manufacturer Trauson (Jiangsu) Holdings Company Limited announced details of their planned IPO on the Hong Kong stock exchange on June 14th, 2010. Trauson, founded in 1986 and based in Changzhau, China, manufactures more than 2,000 devices for... more

Senate Rejects Doc Fix Legislation BY LAUREN UZDIENSKI, JUNE 17, 2010

Legislation that included a wide range of economic benefits, including an 18-month patch on a 21% cut to physician Medicare pay, was effectively rejected by the Senate yesterday. With a 52-45 procedural vote, the bill lacked the support of even a simple majority and missed the 60 votes the legislation would need to withstand a Republican filibuster. more

Musculoskeletal News Roundup 17-Jun-10 BY LAUREN UZDIENSKI, JUNE 17, 2010

Orthopaedic Synergy closes acquisition of PRAXIM . . . Trauson reveals IPO details . . . HyperBranch Medical Technology receives CE mark for a spine sealant . . . TriMed and Stryker back in court over wrist fixation device . . . Bacterin signs deal with hospital purchasing group Broadlane . . . Inion files for bankruptcy . . . BONESUPPORT and TSON announce Board appointments more

Connecticut Researchers Turn Stem Cells into Chondrocytes BY LAUREN UZDIENSKI, JUNE 14, 2010

In April, a team of University of Connecticut researchers published a paper on their "direct, rapid, progressive, and substantially uniform" method of developing embryonic stem cells into chondrocytes, the cells that form cartilage. Now a profile published on UConn's website walks readers through the process of developing the technology and how the team is working to commercialize it. more

President Obama Urges Congress to Pass Doc Fix BY LAUREN UZDIENSKI, JUNE 14, 2010

A 21% reduction to physician Medicare pay is set to take effect this week if Congress doesn't act to avert the reduction, and President Obama is lobbying legislators to block the cuts. In his weekly radio address, the president said that the majority of Congress is prepared to avert cuts, adding that Senate Republicans were holding up legislation that would raise pay by 2% this year. The GOP counters that the cost of the bill is too great. more

Musculoskeletal News Roundup 10-June-10 BY LAUREN UZDIENSKI, JUNE 10, 2010

M&A The Quebec Superior Court authorized the sale of BioSyntech's assets to Piramal Healthcare. Piramal will acquire assets and assume certain BioSyntech liabilities for CAN $3.9 million ($3.7 million). The sale should close within 15 business days. Funding According to... more

Medtronic Analyst Day 2010: Reporting on MDT's Spinal Unit and Acquisition Activity BY SANDER DUNCAN, JUNE 8, 2010

Medtronic (MDT) centered its June 7, 2010 analyst day on how to leverage its size and scale in an increasingly competitive market. MDT does not plan to grow through large-scale acquisition, with chairman and chief executive Bill Hawkins noting that... more

Tornier Files for IPO BY JOHN MCCORMICK, JUNE 8, 2010

Despite recent market turmoil, fast-growing extremities implant leader Tornier made a confident statement about its business outlook by filing for a $205 million initial public offering (IPO) yesterday. After a 16-month nuclear winter, healthcare IPOs came back with a vengeance... more

Another Deadline Passes for Doc Fix BY LAUREN UZDIENSKI, JUNE 4, 2010

Congress was due to act on the looming 21% cut to physician Medicare pay by June 1, when the prior patch expired, but the ongoing Memorial Day recess means legislators won't vote on a bill until at least Monday, June 7th. CMS says they won't process payments for 10 business days, giving the Senate a chance to reconvene and vote on another patch. Rinse, repeat. more

Musculoskeletal News Roundup 3-Jun-10 BY LAUREN UZDIENSKI, JUNE 3, 2010

Mazor announces first German GO-LIF sales . . . OrthoDynamix launches the ArthroSteer Biter . . . Osprey Biomedical introduces the Eagle Cervical Allograft Series . . . DOJ settles with Idaho orthopedists . . . Stryker and Wright Medical settle knee infringement suit . . . Amedica awarded patent . . . AOFAS releases position paper on total ankle replacement . . . Pioneer Surgical announces NuBac data . . . RepRegen reports StronBone data . . . Medtronic to report physician payments greater than $5,000, and Steve La Neve steps down from spine & biologics more

BioMimetic Hiring a Sales Force for Augment BY LAUREN UZDIENSKI, JUNE 2, 2010

BMTI.pngBioMimetic plans to launch Augment in the U.S. with a mix of 100 independent and direct sales reps, whom they say will cover about 75% of all U.S. foot and ankle procedures. The company intends to increase their sales force to 150 to 200 reps within two to three years of Augment's launch. Internationally, the company will set up independent distributors or partners in Europe and Australia and has a partnership in place in Canada. more

Billion-Dollar Tax Credit to Support Research at Small Biotechs BY SANDER DUNCAN, JUNE 1, 2010

Seeking to spur innovative biomedical research by small firms, the IRS and HHS recently announced guidelines for a $1 billion "Therapeutic Discovery Tax Credit." Effective immediately, the tax credit covers up to 50% of firms' investments in qualifying research initiatives made in 2009 and 2010, with up to $5 million available to each company. Firms must have 250 employees or fewer to be eligible, and newer firms that have yet to turn a profit can take the credit as a cash grant instead. more

Complete Archive